Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Liposome formulation of cisplatin enters clinical trials

Dec. 20, 1996

Milestone reached in Genset-Synthelabo collaboration

Dec. 20, 1996

Mercian discovers other anthracycline antineoplastic agents

Dec. 20, 1996

Heterologous vectors for boosting antitumor immunity available for licensing

Dec. 19, 1996

Licensees sought for vector for polynucleotide vaccines

Dec. 19, 1996

Circularly permuted proteins and fusion proteins available for licensing

Dec. 19, 1996

Clinical trial on OXiGENE's Sensamide/Neu-Sensamide nearing completion

Dec. 19, 1996

Positive phase II results with RMP-7/carboplatin

Dec. 19, 1996

Prostate cancer gene therapy trial commences

Dec. 19, 1996

Antineoplastic anthracycline antibiotic disclosed by Mercian

Dec. 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...